India · Delayed Price · Currency is INR Unichem Laboratories Statistics
Total Valuation
NSE:UNICHEMLAB has a market cap or net worth of INR 35.33 billion. The enterprise value is 39.04 billion.
| Market Cap | 35.33B |
| Enterprise Value | 39.04B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 70.41M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.21% |
| Shares Change (QoQ) | -0.51% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 20.17M |
Valuation Ratios
The trailing PE ratio is 28.27.
| PE Ratio | 28.27 |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 31.23 |
| EV / Sales | 1.81 |
| EV / EBITDA | 15.77 |
| EV / EBIT | 31.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | n/a |
| Interest Coverage | 5.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.78% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.86M |
| Profits Per Employee | 397,772 |
| Employee Count | 3,142 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:UNICHEMLAB has paid 127.80 million in taxes.
| Income Tax | 127.80M |
| Effective Tax Rate | 9.28% |
Stock Price Statistics
The stock price has decreased by -11.57% in the last 52 weeks. The beta is -0.15, so NSE:UNICHEMLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | -11.57% |
| 50-Day Moving Average | 575.22 |
| 200-Day Moving Average | 661.52 |
| Relative Strength Index (RSI) | 38.36 |
| Average Volume (20 Days) | 56,272 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:UNICHEMLAB had revenue of INR 21.54 billion and earned 1.25 billion in profits. Earnings per share was 17.76.
| Revenue | 21.54B |
| Gross Profit | 11.80B |
| Operating Income | 1.23B |
| Pretax Income | 1.38B |
| Net Income | 1.25B |
| EBITDA | 2.40B |
| EBIT | 1.23B |
| Earnings Per Share (EPS) | 17.76 |
Balance Sheet
The company has 895.80 million in cash and 4.60 billion in debt, giving a net cash position of -3.70 billion.
| Cash & Cash Equivalents | 895.80M |
| Total Debt | 4.60B |
| Net Cash | -3.70B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 24.51B |
| Book Value Per Share | 348.07 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 54.78%, with operating and profit margins of 5.71% and 5.80%.
| Gross Margin | 54.78% |
| Operating Margin | 5.71% |
| Pretax Margin | 6.39% |
| Profit Margin | 5.80% |
| EBITDA Margin | 11.15% |
| EBIT Margin | 5.71% |
| FCF Margin | n/a |
Dividends & Yields
NSE:UNICHEMLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.21% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.54% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 21, 2010. It was a forward split with a ratio of 2.5.
| Last Split Date | Oct 21, 2010 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |